Phosphorylation of FTDP-17 Mutant tau by Cyclin-dependent Kinase 5 Complexed with p35, p25, or p39
Open Access
- 1 September 2005
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 280 (36), 31522-31529
- https://doi.org/10.1074/jbc.m504792200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Tau pathology in Alzheimer disease and other tauopathiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Tau phosphorylation: physiological and pathological consequencesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- The significance of tau and α-synuclein inclusions in neurodegenerative diseasesCurrent Opinion in Genetics & Development, 2001
- Neurodegenerative TauopathiesAnnual Review of Neuroscience, 2001
- Structure, Microtubule Interactions, and Paired Helical Filament Aggregation by Tau Mutants of Frontotemporal DementiasBiochemistry, 2000
- Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17Science, 1998
- Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assemblyFEBS Letters, 1998
- Mutation in the tau gene in familial multiple system tauopathy with presenile dementiaProceedings of the National Academy of Sciences, 1998
- Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17Nature, 1998
- Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnnals of Neurology, 1998